Humacyte, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Humacyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Humacyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.44M, a 21.9% decline year-over-year.
  • Humacyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $6.07M, a 10.7% decline year-over-year.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.83M, a 10.4% increase from 2022.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.18M, a 39.1% decline from 2021.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.1M, a 116% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.83M +$644K +10.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.18M -$3.96M -39.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $10.1M +$5.45M +116% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $4.69M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.